<DOC>
	<DOCNO>NCT00019331</DOCNO>
	<brief_summary>RATIONALE : Vaccines make peptide may make body build immune response kill tumor cell . Combining vaccine therapy interleukin-2 and/or sargramostim may effective treatment solid tumor . PURPOSE : Phase II trial study effectiveness vaccine therapy plus interleukin-2 and/or sargramostim treat adult metastatic solid tumor .</brief_summary>
	<brief_title>Vaccine Therapy Plus Biological Therapy Treating Adults With Metastatic Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether endogenous cellular immunity tumor-specific mutate ra protein present cancer patient . - Determine whether vaccination synthetic peptide correspond tumor 's ras mutation DetoxPC adjuvant , interleukin-2 ( IL-2 ) , and/or sargramostim ( GM-CSF ) induce boost patient 's cellular immunity particular mutation . - Determine type characteristic cellular immune response generate . - Determine tolerance toxicity spectrum peptide give DetoxPC adjuvant along IL-2 and/or GM-CSF . - Correlate immune response tumor response patient treat regimen . OUTLINE : Patients assign one three treatment group . - Group I ( close accrual 6/4/01 ) : Patients receive tumor-specific ra peptide vaccine DetoxPC subcutaneously ( SC ) every 5 week 3 course . Beginning 4 day vaccination , patient receive interleukin-2 ( IL-2 ) SC 5 day week 2 week . - Group II ( close accrual 6/4/01 ) : Patients receive sargramostim ( GM-CSF ) SC daily begin 1 day prior vaccination continue 4 day . Patients receive vaccination group I immediately follow GM-CSF day 2 . Patients vaccinate every 4 week 3 course . - Group III : Patients receive vaccination IL-2 group I GM-CSF group II . In group , patient receive 15 vaccination absence disease progression . Patients follow every 2 month . PROJECTED ACCRUAL : A maximum 60 patient ( 20 per treatment group ) accrue study within 2-4 year .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Aldesleukin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm solid tumor potentially express mutant ra , include colon , lung , pancreas , thyroid , endometrial , head neck , testicular , hepatocellular , melanoma Ras mutation must one follow point mutation codon 12 : Glycine cysteine Glycine aspartic acid Glycine valine Metastatic disease know chemotherapy radiotherapy would increase survival Tumor tissue must available determination ra mutation No prior CNS metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 01 Life expectancy : More 3 month Hematopoietic : WBC least 2,000/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 2.0 mg/dL SGOT/SGPT great 4 time normal No hepatitis B C infection Renal : Creatinine great 2.0 mg/dL Cardiovascular : No active ischemic heart disease ( New York Heart Association class III IV ) No myocardial infarction within past 6 month No history congestive heart failure , ventricular arrhythmia , arrhythmias require therapy Immunologic : No prior allergy egg No prior autoimmune disease , include follow : Autoimmune neutropenia , thrombocytopenia , hemolytic anemia Systemic lupus erythematosus , Sjogren 's syndrome , scleroderma Myasthenia gravis Goodpasture syndrome Addison 's disease , Hashimoto 's thyroiditis , active Graves ' disease Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception HIV negative No active malignancy except curatively treat carcinoma situ cervix basal cell skin cancer No active infection require antibiotic No medical condition would preclude study PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior immunotherapy recover Chemotherapy : See Disease Characteristics At least 4 week since prior chemotherapy recover Endocrine therapy : At least 4 week since prior steroid recover Radiotherapy : See Disease Characteristics At least 4 week since prior radiotherapy recover Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>advanced adult primary liver cancer</keyword>
	<keyword>recurrent adult primary liver cancer</keyword>
	<keyword>stage IV endometrial carcinoma</keyword>
	<keyword>recurrent endometrial carcinoma</keyword>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>stage IV papillary thyroid cancer</keyword>
	<keyword>stage IV follicular thyroid cancer</keyword>
	<keyword>thyroid gland medullary carcinoma</keyword>
	<keyword>anaplastic thyroid cancer</keyword>
	<keyword>recurrent thyroid cancer</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>adult primary hepatocellular carcinoma</keyword>
	<keyword>pulmonary carcinoid tumor</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV basal cell carcinoma lip</keyword>
	<keyword>stage IV verrucous carcinoma oral cavity</keyword>
	<keyword>stage IV mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage IV adenoid cystic carcinoma oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent basal cell carcinoma lip</keyword>
	<keyword>recurrent verrucous carcinoma oral cavity</keyword>
	<keyword>recurrent mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>recurrent adenoid cystic carcinoma oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV lymphoepithelioma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent lymphoepithelioma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV verrucous carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent verrucous carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>insular thyroid cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>